von Witzleben M, von Witzleben A, Hoffmann T, Hahn J
World J Otorhinolaryngol Head Neck Surg. 2025; 11(1):45-51.
PMID: 40070493
PMC: 11891276.
DOI: 10.1002/wjo2.139.
Taylor K, DiBlasi M, Pedersen E, Shahsavari N
Radiol Case Rep. 2024; 20(1):705-710.
PMID: 39610445
PMC: 11602968.
DOI: 10.1016/j.radcr.2024.10.056.
Fujita Y, Takise Y, Masuyama Y, Nakajima I, Nozawa Y, Ishida K
Cureus. 2024; 16(10):e71489.
PMID: 39559656
PMC: 11571279.
DOI: 10.7759/cureus.71489.
Uwagba G, Joseph A, Habeebu M, Aje E, Oladipo A, Fagbemide O
Ecancermedicalscience. 2024; 18:1770.
PMID: 39430069
PMC: 11489088.
DOI: 10.3332/ecancer.2024.1770.
Jiang W, Zheng B, Wei H
Discov Oncol. 2024; 15(1):365.
PMID: 39177900
PMC: 11343961.
DOI: 10.1007/s12672-024-01242-3.
Salivary Gland Anlage Tumor: A Case Report on Abnormal Breathing Found in a Late-Preterm Infant.
Han A, Bruett C, Thomas K, Htun Z, Taufique Z
Cureus. 2024; 16(7):e64921.
PMID: 39156296
PMC: 11330639.
DOI: 10.7759/cureus.64921.
Tumor Infiltrating Lymphocytes as an Independent Prognostic Factor in Undifferentiated Nasopharyngeal Carcinoma.
Febriani V, Indrawati I, Sumpono A, Ferronika P, Bawono R, Dwianingsih E
Asian Pac J Cancer Prev. 2024; 25(6):1997-2002.
PMID: 38918661
PMC: 11382859.
DOI: 10.31557/APJCP.2024.25.6.1997.
Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma.
Jiang W, Lv J, Tang L, Sun Y, Chen Y, Ma J
Cell Rep Med. 2024; 5(6):101594.
PMID: 38843843
PMC: 11228659.
DOI: 10.1016/j.xcrm.2024.101594.
Precision Medicine for Nasopharyngeal Cancer-A Review of Current Prognostic Strategies.
Suryani L, Lee H, Teo W, Chin Z, Loh K, Tay J
Cancers (Basel). 2024; 16(5).
PMID: 38473280
PMC: 10931317.
DOI: 10.3390/cancers16050918.
Ophthalmic manifestations of nasopharyngeal carcinoma (NPC): A systematic review of reported cases with and without prior history of nasopharyngeal carcinoma.
Alkatan H, Alrashed S, Maktabi A
Arq Bras Oftalmol. 2024; 87(2):e20220241.
PMID: 38451680
PMC: 11620173.
DOI: 10.5935/0004-2749.2022-0241.
Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect.
Siak P, Heng W, Teoh S, Lwin Y, Cheah S
J Transl Med. 2023; 21(1):786.
PMID: 37932756
PMC: 10629096.
DOI: 10.1186/s12967-023-04673-8.
Impact of independent multidisciplinary work on the survival rate of stage 3 and 4 nasopharyngeal cancer in Indonesia: a retrospective cohort study.
Rizky D, Yunarvika V, Putra Y, Pangarsa E, Kartiyani I, Panunggal D
Ann Med Surg (Lond). 2023; 85(9):4248-4255.
PMID: 37663678
PMC: 10473326.
DOI: 10.1097/MS9.0000000000001074.
Synchronous Nasopharyngeal and Thyroid Malignancies: A Case Report.
Basyuni M, Altowairqi A, Khan M, Bahaj A, Alharbi J, Alessa M
Cureus. 2023; 15(7):e41674.
PMID: 37575697
PMC: 10412943.
DOI: 10.7759/cureus.41674.
Epidemiology and demographics of head and neck cancer in Africa: A scoping review.
Seedat J, Coutts K, Vlok E
Afr J Prim Health Care Fam Med. 2023; 15(1):e1-e13.
PMID: 37526561
PMC: 11022662.
DOI: 10.4102/phcfm.v15i1.3749.
High-throughput identification of regulatory elements and functional assays to uncover susceptibility genes for nasopharyngeal carcinoma.
Wang T, Xiao R, He Y, Zhang W, Diao H, Tang M
Am J Hum Genet. 2023; 110(7):1162-1176.
PMID: 37352861
PMC: 10357478.
DOI: 10.1016/j.ajhg.2023.06.003.
Imaging of pharyngeal pathology.
Rahim I, Napolitano A, Burd C, Lingam R
Br J Radiol. 2023; 96(1149):20230046.
PMID: 37334795
PMC: 10461270.
DOI: 10.1259/bjr.20230046.
Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?.
Juarez-Vignon Whaley J, Afkhami M, Sampath S, Amini A, Bell D, Villaflor V
Curr Treat Options Oncol. 2023; 24(7):845-866.
PMID: 37145382
PMC: 10271909.
DOI: 10.1007/s11864-023-01083-2.
Radiomics Applications in Head and Neck Tumor Imaging: A Narrative Review.
Tortora M, Gemini L, Scaravilli A, Ugga L, Ponsiglione A, Stanzione A
Cancers (Basel). 2023; 15(4).
PMID: 36831517
PMC: 9954362.
DOI: 10.3390/cancers15041174.
Increased Prevalence of EBV Infection in Nasopharyngeal Carcinoma Patients: A Six-Year Cross-Sectional Study.
Al-Anazi A, Alanazi B, Alshanbari H, Masuadi E, Hamed M, Dandachi I
Cancers (Basel). 2023; 15(3).
PMID: 36765601
PMC: 9913071.
DOI: 10.3390/cancers15030643.
Nomogram to Predict Long-Term Overall Survival and Cancer-Specific Survival of Radiotherapy Patients with Nasopharyngeal Carcinoma.
Li Z, Li C, Yang D, Zhou Z, Kang M
Biomed Res Int. 2023; 2023:7126881.
PMID: 36704722
PMC: 9873435.
DOI: 10.1155/2023/7126881.